spacer
home > white papers > Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences - Myoderm
WHITE PAPERS
logo_Myoderm.JPG

Myoderm

phone +1 610-233-3300
email sales@myoderm.com
web http://www.myoderm.com
email 48 East Main Street, Norristown, PA 19401 USA

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Samsung Biologics Reports Third Quarter 2022 Financial Results

Recorded consolidated revenue of KRW 873 billion in Q3’22, and recorded consolidated operating profit of KRW 324.7 billion in Q3’22. Also started partial operations at Plant 4 within 23 months since groundbreaking as previously committed and launched two
More info >>


White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement